Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

JM Dulhunty, JA Roberts, JS Davis… - Clinical infectious …, 2013 - academic.oup.com
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

Continuous infusion of beta-lactam antibiotics in severe sepsis: A multicenter double-blind, randomized controlled trial

J Dulhunty, J Roberts, J Davis… - Journal of …, 2013 - researchers.cdu.edu.au
Background: Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

J Dulhunty, J Roberts, J Davis… - Clinical Infectious …, 2013 - researchnow.flinders.edu.au
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

[PDF][PDF] Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

JM Dulhunty, JA Roberts, JS Davis… - Clinical Infectious …, 2013 - scholar.archive.org
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

[PDF][PDF] Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

JM Dulhunty, JA Roberts, JS Davis… - Clinical Infectious …, 2013 - criticalcare.queensu.ca
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

[引用][C] Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicentre double-blind, randomised controlled trial

JM Dulhunty, JA Roberts, JS Webb… - Clinical Infectious …, 2013 - espace.library.uq.edu.au
This study aims to determine if continuous infusion (CI) is associated with better clinical and
pharmacokinetic/pharmacodynamic (PK/PD) outcomes compared to intermittent bolus (IB) …

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial

J Dulhunty, JA Roberts, JS Davis… - Clinical Infectious …, 2013 - research.monash.edu
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

[PDF][PDF] Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

JM Dulhunty, JA Roberts, JS Davis, SAR Webb… - 2012 - researchgate.net
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …

[引用][C] Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind, Randomized Controlled Trial

JM Dulhunty, JA Roberts, JS Davis, SAR Webb… - Clinical Infectious …, 2012 - cir.nii.ac.jp
Continuous Infusion of Beta-Lactam Antibiotics in Severe Sepsis: A Multicenter Double-Blind,
Randomized Controlled Trial | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ …

Continuous infusion of beta-lactam antibiotics in severe sepsis: a multicenter double-blind, randomized controlled trial.

JM Dulhunty, JA Roberts, JS Davis, SAR Webb… - 2013 - cabidigitallibrary.org
Background. Beta-lactam antibiotics are a commonly used treatment for severe sepsis, with
intermittent bolus dosing standard therapy, despite a strong theoretical rationale for …